Author

Madeline King

University of California, Davis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Jennifer Lynne WhistleriD· 2 shared Anirudh GauriD· 1 shared Bethany P. CummingsiD· 1 shared Caroline M. Keeshen· 1 shared Christina K. KimiD· 1 shared Elinor Lewis· 1 shared Jessie MuiriD· 1 shared Julianna Glienke· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Jennifer Lynne WhistlerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintApr 15, 2025

D3 dopamine receptors implicate a striatal neuronal subtype in the aversive effects of the antipsychotic drug quetiapine

Elinor Lewis, Jessie Muir, Ying C. Li…·Jennifer Lynne Whistler

This study identifies D3R-expressing neurons in the NAc as mediators of quetiapine's aversive effects, showing that chronic treatment reduces this aversion.

DOI 10.1101/2025.04.15.649037

mousescRNA-seq

𝕏 PostBluesky

Cell BiologybioRxivPreprintAug 9, 2024

G protein-Coupled Receptor Associated Sorting ProteinGASP1 mediated trafficking of the Glucagon Like Peptide-1Receptor contributes to the development of tolerance toincretin drugs

Anirudh Gaur, Caroline M. Keeshen, Madeline King…·Jennifer L. Whistler

This study shows that GASP1-mediated GLP-1R trafficking contributes to tolerance to incretin drugs, suggesting a strategy to prevent tolerance by biasing drug engagement toward G protein signaling.

DOI 10.1101/2024.08.09.607397

mouseexperimental assay

𝕏 PostBluesky